Logo image of MEIP

MEI PHARMA INC (MEIP) Stock Analyst Ratings

NASDAQ:MEIP - Nasdaq - US55279B3015 - Common Stock - Currency: USD

4.87  -0.28 (-5.44%)

After market: 5 +0.13 (+2.67%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to MEIP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.12. This target is 25.67% above the current price.
MEIP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about MEIP.
In the previous month the buy percentage consensus was at a similar level.
MEIP was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

MEIP Historical Analyst RatingsMEIP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -103 -93 -83 -73 -63 -53 -43 -33 -23 -13 -3 5 10 15

Price Target & Forecast

Price Low Median Mean High 4.876.066.126.126.30 - 24.44% 25.67% 25.67% 29.36%

Related screens

MEIP Current Analyst RatingMEIP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-07-23 Laidlaw & Co. Downgrade Buy -> Hold
2024-04-12 Stifel Maintains Hold -> Hold
2024-02-14 Stifel Maintains Hold -> Hold
2023-09-27 Stifel Maintains Hold -> Hold
2023-05-23 Brookline Capital Maintains Buy -> Buy
2023-05-12 Stifel Maintains Hold -> Hold
2023-02-13 HC Wainwright & Co. Maintains Buy
2023-02-08 Jefferies Downgrade Hold -> Underperform
2022-12-06 BTIG Downgrade Buy -> Neutral
2022-12-06 Truist Securities Downgrade Buy -> Hold
2022-02-03 Jefferies Initiate Buy